Thomas J. Herzfeld Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-6
| Closed | -$4.94K | – | 303 |
|
|
2023
Q3 | $4.94K | Sell |
6
-1
| -14% | -$823 | ﹤0.01% | 247 |
|
|
2023
Q2 | $4.96K | Sell |
7
-1
| -13% | -$708 | ﹤0.01% | 253 |
|
|
2023
Q1 | $6.57K | Hold |
8
| – | – | ﹤0.01% | 193 |
|
|
2022
Q4 | $5.77K | Hold |
8
| – | – | ﹤0.01% | 213 |
|
|
2022
Q3 | $6K | Hold |
8
| – | – | ﹤0.01% | 189 |
|
|
2022
Q2 | $5K | Hold |
8
| – | – | ﹤0.01% | 219 |
|
|
2022
Q1 | $6K | Hold |
8
| – | – | ﹤0.01% | 217 |
|
|
2021
Q4 | $5K | Hold |
8
| – | – | ﹤0.01% | 276 |
|
|
2021
Q3 | $5K | Hold |
8
| – | – | ﹤0.01% | 262 |
|
|
2021
Q2 | $4K | Buy |
8
+1
| +14% | +$500 | ﹤0.01% | 294 |
|
|
2021
Q1 | $3K | Hold |
7
| – | – | ﹤0.01% | 314 |
|
|
2020
Q4 | $3K | Hold |
7
| – | – | ﹤0.01% | 274 |
|
|
2020
Q3 | $4K | Hold |
7
| – | – | ﹤0.01% | 206 |
|
|
2020
Q2 | $4K | Buy |
+7
| New | +$4K | ﹤0.01% | 243 |
|